Web Updates

Our website changes frequently as we update and add new information. We encourage you to use the “refresh” or “reload” feature on your web browser to ensure that you view our website’s current version. If you would like to receive email messages notifying you of when an update to our website has occurred, please email us at ocaswebupdates@cdc.gov with your request.


Friday, January 23, 2026

2026 Advisory Board and Public Meetings

February

  1. Presentations for the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue):

    • SC&A Presentation: SC&A Comments on NIOSH White Paper, “A Discussion of Completeness in Co-Exposure Models”

    • SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”

January

  1. Presentations for the January 29, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Pinellas Plant:

    • SC&A Presentation: SC&A Supplemental Review of SEC-00256 Petition Evaluation Report for Pinellas Plant

  2. Presentations for the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews:

    • SC&A Presentation: A Review of NIOSH’s Program Evaluation Report DCAS-PER-034, “Harshaw Chemical Company TBD Revision”

    • SC&A Presentation: DCAS-PER-083, Subtask 4: Review of Two Advisory Board-Selected Cases Reworked for the Evaluation of DCAS-PER-083

    • SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-039, “Baker Perkins TBD Revision”

Advisory Board: Reports from the Technical Support Contractor

Index — B

  1. Baker-Perkins Co.:

    • SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-039, “Baker Perkins TBD Revision”
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Index — C

  1. Coworker Datasets, Models, and Studies:

    • SC&A Presentation: SC&A Comments on NIOSH White Paper, “A Discussion of Completeness in Co-Exposure Models”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Index — H

  1. Harshaw Chemical Company:

    • SC&A Presentation: A Review of NIOSH’s Program Evaluation Report DCAS-PER-034, “Harshaw Chemical Company TBD Revision”
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Index — M

  1. Mound Plant:

    • SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Index — N

  1. Nevada Test Site:

    • SC&A Presentation: SC&A Comments on NIOSH White Paper, “A Discussion of Completeness in Co-Exposure Models”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Index — P

  1. Pinellas Plant:

    • SC&A Presentation: SC&A Supplemental Review of SEC-00256 Petition Evaluation Report for Pinellas Plant
      (Presentation at the January 29, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Pinellas Plant)

  2. Program Evaluation Reports (PERs):

    • SC&A Presentation: A Review of NIOSH’s Program Evaluation Report DCAS-PER-034, “Harshaw Chemical Company TBD Revision”
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

    • SC&A Presentation: DCAS-PER-083, Subtask 4: Review of Two Advisory Board-Selected Cases Reworked for the Evaluation of DCAS-PER-083
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

    • SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-039, “Baker Perkins TBD Revision”
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Index — S

  1. Savannah River Site:

    • SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Index — T

  1. Technical Documents (Technical Information Bulletins):

    • SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Index — W

  1. Weldon Spring Plant:

    • SC&A Presentation: DCAS-PER-083, Subtask 4: Review of Two Advisory Board-Selected Cases Reworked for the Evaluation of DCAS-PER-083
      (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Index — Y

  1. Y-12 Plant:

    • SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
      (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Baker-Perkins Co.

Advisory Board and NIOSH Discussions on Baker-Perkins Co.

  1. SC&A Presentation: Review of NIOSH’s Program Evaluation Report DCAS-PER-039, “Baker Perkins TBD Revision”
    (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Harshaw Chemical Company

Advisory Board and NIOSH Discussions on Harshaw Chemical Company

  1. SC&A Presentation: A Review of NIOSH’s Program Evaluation Report DCAS-PER-034, “Harshaw Chemical Company TBD Revision”
    (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Mound Plant

Advisory Board and NIOSH Discussions on Mound Plant

  1. SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
    (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Pinellas Plant

Advisory Board Work Group on the Pinellas Plant

  1. Presentations for the January 29, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Pinellas Plant:

    • SC&A Presentation: SC&A Supplemental Review of SEC-00256 Petition Evaluation Report for Pinellas Plant

Advisory Board and NIOSH Comments and Discussion Papers on Pinellas Plant

  1. SC&A Presentation: SC&A Supplemental Review of SEC-00256 Petition Evaluation Report for Pinellas Plant
    (Presentation at the January 29, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Pinellas Plant)

Savannah River Site (SRS)

Advisory Board and NIOSH Discussions on Savannah River Site (SRS)

  1. SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
    (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Weldon Spring Plant

Advisory Board and NIOSH Comments and Discussion Papers on Weldon Spring Plant

  1. SC&A Presentation: DCAS-PER-083, Subtask 4: Review of Two Advisory Board-Selected Cases Reworked for the Evaluation of DCAS-PER-083
    (Presentation at the January 28, 2026, Teleconference Meeting of the Subcommittee for Procedure Reviews)

Y-12 Plant

Advisory Board and NIOSH Comments and Discussions on the Y-12 Plant

  1. SC&A Presentation: SC&A’S Evaluation of ORAUT-OTIB-0075, Revision 01, “Use of Claimant Datasets for Coworker Modeling”
    (Presentation at the February 11, 2026, Teleconference Meeting of the Advisory Board’s Work Group on the Special Exposure Cohort (SEC) Issues (including the 250 day issue))

Previous Updates